The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Educational Lecture

Educational Lecture 2-3E Adverse events of ABL tyrosine kinase inhibitors in chronic myeloid leukemia therapy

Sun. Oct 14, 2018 9:40 AM - 10:10 AM No.15 (Osaka International Convention Center, 7F 701-2)

Chair: Arinobu Tojo (Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Japan)

[EL2-3E] Adverse events of ABL tyrosine kinase inhibitors in chronic myeloid leukemia therapy

Tetsuzo Tauchi (Department of Hematology, Tokyo Medical University, Japan)